PUBLISHER: Global Insight Services | PRODUCT CODE: 1598357
PUBLISHER: Global Insight Services | PRODUCT CODE: 1598357
The AI in drug discovery market is anticipated to expand from $1.2 billion in 2023 to $10.1 billion by 2033, reflecting a CAGR of 23.2%.
The Artificial Intelligence for Drug Discovery market encompasses the application of AI technologies to enhance and expedite the drug discovery process. It involves machine learning, deep learning, and data analytics to identify novel drug candidates, optimize drug design, and predict therapeutic outcomes. This market is pivotal in reducing time and costs associated with traditional drug development, offering transformative potential in personalized medicine and rare disease treatments, thereby revolutionizing pharmaceutical research and development.
The Artificial Intelligence for Drug Discovery market is witnessing robust expansion, driven by advancements in machine learning and computational biology. The lead sub-segment is the target identification and validation segment, leveraging AI to streamline the identification of novel drug targets. The second-highest performing sub-segment is the molecule screening and design, where AI algorithms expedite the development of potential drug candidates. Regionally, North America stands at the forefront, benefiting from a strong technological ecosystem and substantial R&D investments. Europe follows closely, with notable contributions from countries like the United Kingdom and Germany, where supportive government policies and collaborations between academia and industry foster innovation. Asia-Pacific is emerging as a significant player, driven by increasing investments in healthcare infrastructure and a burgeoning biotechnology sector. This region's growth is further propelled by the strategic focus on precision medicine and the integration of AI in pharmaceutical research, promising lucrative opportunities for stakeholders.
Key Companies
Insilico Medicine, Exscientia, Benevolent AI, Atomwise, Recursion Pharmaceuticals, Schrudinger, Cyclica, Bio Symetrics, Verge Genomics, Xtal Pi, Deep Genomics, Valo Health, Two XAR, Numerate, Cloud Pharmaceuticals, Aria Pharmaceuticals, Path AI, Peptone, Healx, Inveni AI
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.